Search Main Menu Main Content

Choose language
Change contrast :
Standards Reinforced

icone

HAS profile

Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest

International relations and projects
Publications

Recherche

icone plus
My account

Email alert Subscription

Newsletter Subscription

My search

Refresh

Please fill in your email address to retrieve your email alerts subscriptions.

New subscription

Please fill in your email address to retrieve your newsletter subscriptions.

You do not have a saved search
No element in selection
Contact

1 result

Active substance : fructose
Active substance : lysine
Active substance : glycine

Topic

Diseases and conditions (1)
Plus ...

Practice Guidelines and Other Guides (1)
Plus ...
- Chronic disease guide (1)

Français (1)

Active substance

cuivre (1)
fer (1)
fructose (1)
glycine (1)
histidine (1)
lysine (1)
miglustat (1)
tryptophane (1)
tyrosine (1)
zinc (1)

Practice guidelines and other guides - 1 result

Gaucher disease

Chronic disease guide - Posted on 11/5/2007

Download guide

Add to my selection

Advancing quality in the fields of health and social care services

Follow us :

Eunetha.eu
Pasq.eu

All our publications by topic and type

Opinions on medicines
Opinions on medical devices
INAHTA briefs

Français
English

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

KELZrJ9QFkpwjCMk